Prevalence and clinical aspects of obstructive sleep apnea in Parkinson disease: A meta‐analysis
European Journal of Neurology · 2024-02 · 31 (2)
DOI: 10.1111/ene.16109 ↗Kurz gefasst
Metaanalyse in der Zeitschrift European Journal of Neurology, online erschienen am 03.11.2023. Verfasst von Gianpaolo Maggi und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Psychology, University of Campania "Luigi Vanvitelli", Caserta, Italy. Hauptthemen laut MEDLINE: Parkinson Disease, REM Sleep Behavior Disorder, Sleep Apnea, Obstructive. Die Arbeit wurde bisher 37-mal zitiert (Crossref) und nennt 69 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).
Abstract (Originalsprache)
Background and Purpose Obstructive sleep apnea (OSA) frequently occurs in Parkinson Disease (PD), probably caused by upper airway dysfunctions or shared pathogenetic mechanisms. OSA may precede PD diagnosis or worsen throughout its course, but its relationship with clinical features and dopaminergic medication remains unclear. This meta‐analysis aimed to provide a reliable estimate of OSA prevalence in the PD population (PD‐OSA) and to clarify its clinical associated factors to help clinicians in understanding the underlying pathophysiological mechanisms.
Methods
A systematic literature search was performed up to April 2023 using the PubMed, Scopus, and PsycINFO databases. Articles were included if they provided data on PD patients with and without OSA. Pooled prevalence for PD‐OSA was calculated using the proportions of PD participants diagnosed with OSA. Demographic and clinical features associated with PD‐OSA were explored by comparing PD patients with and without OSA.
Results
Seventeen studies were included in the meta‐analysis. Pooled OSA prevalence was 45% of a total sample of 1448 PD patients and was associated with older age, male sex, higher body mass index (BMI), more severe motor disturbances and periodic limb movements, reduced risk of rapid eye movement sleep behavior disorder, intake of dopamine agonists, and worse excessive daytime sleepiness. No relationship emerged with cognitive functioning and neuropsychiatric manifestations.
Conclusions
OSA affects nearly half of PD patients as a secondary outcome of predisposing factors such as older age and higher BMI in addition to PD‐related motor impairment. Future studies should focus on determining the impact of both clinical features and dopaminergic medication on the development of PD‐OSA.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Psychology, University of Campania "Luigi Vanvitelli", Caserta, Italy.
- Department of Neuroscience, Section of Psychiatry, School of Medicine, University of Naples Federico II, Naples, Italy.
- Department of Motor Sciences and Wellness, Parthenope University, Naples, Italy.
- Institute of Diagnosis and Health, IDC-Hermitage Capodimonte, Naples, Italy.
ORCID-Profile: Gianpaolo Maggi, Chiara Giacobbe, Federica Iannotta, Gabriella Santangelo, Carmine Vitale
Zitieren
APA
Maggi, G., Giacobbe, C., Iannotta, F., Santangelo, G., & Vitale, C. (2024). Prevalence and clinical aspects of obstructive sleep apnea in Parkinson disease: A meta‐analysis. European Journal of Neurology, 31(2). https://doi.org/10.1111/ene.16109
Vancouver
Maggi G, Giacobbe C, Iannotta F, Santangelo G, Vitale C. Prevalence and clinical aspects of obstructive sleep apnea in Parkinson disease: A meta‐analysis. European Journal of Neurology. 2024;31(2). doi:10.1111/ene.16109
BibTeX
@article{Maggi2024,
author = {Maggi, Gianpaolo and Giacobbe, Chiara and Iannotta, Federica and Santangelo, Gabriella and Vitale, Carmine},
title = {Prevalence and clinical aspects of obstructive sleep apnea in Parkinson disease: A meta‐analysis},
journal = {European Journal of Neurology},
year = {2024},
volume = {31},
number = {2},
doi = {10.1111/ene.16109}
}
EUVIMED